19.01.2013 Views

2012 thomson reuters australia citation & innovation awards

2012 thomson reuters australia citation & innovation awards

2012 thomson reuters australia citation & innovation awards

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>2012</strong> THOMSON REUTERS AUSTRALIA<br />

CITATION & INNOVATION AWARDS<br />

30 MAY <strong>2012</strong>, NATIONAL PRESS CLUB, CANBERRA<br />

How Australia is influencing the global research<br />

and <strong>innovation</strong> landscape


<strong>2012</strong> THOMSON REUTERS AUSTRALIA<br />

CITATION & INNOVATION AWARDS<br />

30 MAY <strong>2012</strong>, NATIONAL PRESS CLUB, CANBERRA<br />

WELCOME 02<br />

PROGRAM 03<br />

SPEAKERS 04<br />

METHODOLOGY 09<br />

PROFILES OF THE AWARDEES 1 1<br />

ABOUT THOMSON REUTERS 22<br />

2


WELCOME<br />

Welcome to the <strong>2012</strong> Thomson Reuters Citation & Innovation Awards!<br />

Australia produces over 3% of scholarly and scientific research worldwide. However, in certain fields<br />

Australia’s world share is much higher from 4% to nearly 6%. These fields include environment and<br />

ecology, geosciences and space science. Not only is Australia contributing more in these fields, the<br />

<strong>citation</strong> impact of this research is 30-50% higher than world average.<br />

If we use patenting activity as an indicator of <strong>innovation</strong>, Australia showed a decline following the global<br />

financial crisis, but recent Australian Patent Office data indicates there has been an upturn in patent<br />

filings which may be a sign of a turnaround in <strong>innovation</strong> activity.<br />

Performance indicators based on publication, <strong>citation</strong> and patent data provide one perspective on<br />

research and <strong>innovation</strong> activity, however expert opinion will always help to complete the picture.<br />

Thomson Reuters is pleased to showcase some of our top performers in the industry and also bring<br />

together key players in the sector to address the theme of “how Australia is influencing the global<br />

research and <strong>innovation</strong> landscape”.<br />

We welcome our distinguished speakers to the event. Citation Award winners Professor Ove Hoegh-<br />

Guldberg, University of Queensland and Professor Colin MacLeod, University of Western Australia,<br />

will be providing an academic perspective on Australia’s role and performance in <strong>innovation</strong>. Dr Chris<br />

Roberts as CEO of Cochlear Ltd will be providing the viewpoint from a corporate perspective.<br />

This will be followed by the lunchtime address, which will be a moderated discussion with Professor<br />

Brian Schmidt, Nobel Laureate for Physics and previous Thomson Reuters Citation Award winner<br />

and Dr Alan Finkel, Chancellor of Monash University and President-elect of the Academy of<br />

Technological Sciences and Engineering.<br />

In addition, today is an opportunity for Thomson Reuters to recognise Australia’s excellence with twelve<br />

Australian researchers and seven Australian organisations selected to receive <strong>awards</strong> in recognition<br />

of their outstanding contribution to research and <strong>innovation</strong>. Details on the award winners and<br />

methodology can be found in this program.<br />

We thank you for being part of this prestigious event and look forward to the ongoing dialogue in the<br />

<strong>innovation</strong> ecosystem.<br />

Jeroen Prinsen<br />

Senior Director Australasia<br />

P: +61 2 85877948<br />

jeroen.prinsen@<strong>thomson</strong><strong>reuters</strong>.com<br />

ip-science.<strong>thomson</strong><strong>reuters</strong>.com.au<br />

2


PROGRAM<br />

Time Session Speaker<br />

8:30am Registration and morning tea<br />

9:00am Welcome Address Anna-Maria Arabia<br />

CEO<br />

Science & Technology Australia<br />

9:10am The Science and Art of Using Citation<br />

Indicators to Identify Exceptional Scientists and their<br />

Impact<br />

9:25am Presentation of the <strong>2012</strong> Thomson Reuters<br />

Citation Awards<br />

9:40am How Australia is influencing the global research and<br />

<strong>innovation</strong> landscape: academic perspective<br />

3<br />

Cynthia Murphy<br />

Senior Vice President, IP Solutions<br />

Thomson Reuters<br />

David Pendlebury<br />

Bibliometric Consultant<br />

Thomson Reuters<br />

Cynthia Murphy<br />

Senior Vice President, IP Solutions<br />

Thomson Reuters<br />

Professor Ove Hoegh-Guldberg<br />

University of Queensland<br />

Professor Colin MacLeod<br />

University of Western Australia<br />

10:00am Introduction to the Innovation Awards Cynthia Murphy<br />

Senior Vice President, IP Solutions<br />

Thomson Reuters<br />

10:05am How Australia is influencing the global research and<br />

<strong>innovation</strong> landscape: corporate perspective<br />

Dr Chris Roberts<br />

CEO<br />

Cochlear Ltd<br />

10:25am Metrics & methodology for Innovation <strong>awards</strong> Dr Nicola Lake<br />

IP Solutions Strategist<br />

Thomson Reuters<br />

10:40am Presentation of the <strong>2012</strong> Thomson Reuters<br />

Innovation Awards<br />

Dr Chris Roberts<br />

CEO<br />

Cochlear Ltd<br />

10:55am Thanks and close Cynthia Murphy<br />

Senior Vice President, IP Solutions<br />

Thomson Reuters<br />

11:00am Networking Break<br />

11:45am Lunch served<br />

12:30pm Introduction of keynote speakers Laurie Wilson<br />

President<br />

National Press Club<br />

12:35 –<br />

1:30pm<br />

Lunchtime address televised by<br />

National Press Club<br />

Moderated discussion:<br />

Professor Brian Schmidt<br />

Nobel prize winner 2011<br />

Australian National University<br />

and<br />

Dr Alan Finkel<br />

Chancellor<br />

Monash University


KEYNOTE SPEAKERS<br />

Professor Brian P. Schmidt is a Distinguished Professor, Australian Research<br />

Council Laureate Fellow and astrophysicist at the Australian National University’s<br />

Mount Stromlo Observatory and Research School of Astronomy and Astrophysics.<br />

He is known for his research in using supernovae as cosmological probes. He<br />

currently holds an Australian Research Council Federation Fellowship.<br />

Brian shared both the 2006 Shaw Prize in Astronomy and the 2011 Nobel Prize<br />

in Physics with Saul Perlmutter and Adam Reis for providing evidence that the<br />

expansion of the universe is accelerating. He is also a previous Thomson Reuters<br />

Citation Award winner from 2008.<br />

Brian makes wine and enjoys cooking. He and his wife are owners of the winery<br />

Maipenrai, a winery in Sutton Australia which has been rated a four-star winery.<br />

At the 2011 Nobel Prize Ceremonies in Stockholm, he presented the King Carl XVI<br />

Gustaf of Sweden with a bottle of his wine.<br />

Dr Alan Finkel AM PhD FTSE is Chancellor of Monash University and presidentelect<br />

of the Australian Academy of Technological Sciences and Engineering. He is<br />

a co-founder and chairman of Cosmos Media, publisher of Cosmos Magazine, and<br />

he is the chairman of the Australian Centre of Excellence for All-Sky Astrophysics,<br />

known as CAASTRO.<br />

In addition to an on-going property business, Alan’s most recent employment was<br />

as the Chief Technology Officer of Better Place Australia, a company that provides<br />

clean energy to run Australia’s growing fleet of electric cars. Previously, for twenty<br />

years Alan was the CEO of Axon Instruments, an ASX-listed, American company<br />

that made precision scientific instruments used by researchers at pharmaceutical<br />

companies and universities for the discovery of new medicines.<br />

Alan established and chairs the Australian Course in Advanced Neuroscience to<br />

provide advanced training to young scientists and he established a secondary<br />

school science program named STELR that is currently running in nearly 300<br />

secondary schools around Australia.<br />

4


SPEAKERS<br />

Anna-Maria Arabia is CEO of Science & Technology Australia. Previously<br />

Anna-Maria was a senior policy advisor to Anthony Albanese, Federal<br />

Infrastructure Minister, and was social policy advisor to former Labor Leader, Kim<br />

Beazley. Anna-Maria is a trained scientist completing a Bachelor of Science at the<br />

University of Melbourne and has undertaken post-graduate research at the Baker<br />

Heart Research Institute in Melbourne, and the Mario Negri Pharmacological<br />

Research Institute in Milan.<br />

Cynthia Murphy is senior vice president for Thomson Reuters IP Solutions. She<br />

is responsible for overall management of the Innovation & Asset Management<br />

business, including commercial strategy and operations. Cynthia is a twenty-two<br />

year veteran of Thomson Reuters in a variety of roles of increasing responsibility.<br />

Prior to joining IP Solutions, she was senior vice president, strategic marketing<br />

for Dialog, responsible for world-wide planning and implementation of product<br />

development, marketing, communications and customer service programs.<br />

Previously, Cynthia served as commercial director at Sweet & Maxwell, where she<br />

was accountable for all aspects of the launch and the subsequent commercial<br />

success of Westlaw UK; and she held several positions at West in the sales<br />

organisation. Cynthia started her professional career as a law librarian in Boston.<br />

She is a graduate of the University of Maine and holds a master’s degree in library<br />

and information sciences from Simmons College.<br />

5


SPEAKERS<br />

David A. Pendlebury joined the Institute for Scientific Information (ISI), now<br />

Thomson Reuters, in 1983, after graduate studies in ancient history. He began as<br />

a translator and indexer and later worked with ISI’s founder Eugene Garfield on<br />

personal research projects. In 1987, he developed and edited the research pages<br />

of the newspaper The Scientist. Two years later, he joined the company’s research<br />

department, under Henry Small, to launch the newsletter Science Watch, now in<br />

its 23rd year.<br />

For twelve years, until 2004, David was manager of the department’s contract<br />

research services for government agencies, universities, corporations, and<br />

science publishers worldwide, during which time contract research projects<br />

increased significantly. With Henry and other departmental staff, he designed<br />

and developed Essential Science Indicators, a primary database for quantitative<br />

analysis of performance and trends in global research.<br />

David now serves as a consultant to Thomson Reuters on bibliometric analysis.<br />

He has also written on research metrics and evaluation for the Times Higher<br />

Education magazine and a variety of other publications.<br />

Professor Ove Hoegh-Guldberg (BSc Hons., Sydney; PhD. UCLA) is the inaugural<br />

Director of the Global Change Institute (GCI) (www.gci.uq.edu.au) and Professor<br />

of Marine Science, at The University of Queensland (UQ) (www.uq.edu.au),<br />

Brisbane, Australia. He is deeply-motivated by a desire to communicate science<br />

effectively, undertake game-changing research and to find high-impact solutions<br />

to address several of the most pressing and serious challenges facing humanity<br />

worldwide, such as climate change, food security, clean energy and population<br />

growth.<br />

As Director of the GCI Ove has a key role in engaging with the UQ community<br />

and external stakeholders to create opportunities and build strong external<br />

links and networks for the institute. He heads a large research laboratory (over<br />

30 researchers & students) that focuses on how global warming and ocean<br />

acidification are affecting and will affect coral reefs.<br />

Ove has held academic positions at UCLA, Stanford University, The University<br />

of Sydney and The University of Queensland and is a member of the Australian<br />

Climate Group; the Royal Society (London) Marine Advisory Network; and<br />

the Board of Editing Reviewers at Science Magazine. In 1999 he was awarded<br />

the Eureka Prize for his scientific research. He is the Queensland Smart State<br />

Premier’s Fellow (2008-2013).<br />

6


SPEAKERS<br />

Professor Colin MacLeod is Winthrop Professor of Psychology, Australian<br />

Research Council Professorial Fellow, and Director of the Elizabeth Rutherford<br />

Memorial Centre for the Advancement of Research on Emotion (CARE), at the<br />

University of Western Australia (UWA). Colin completed training both as a<br />

cognitive psychologist, carrying out his research doctorate in this field at Oxford<br />

University, and as a clinician, undertaking clinical psychology training at the<br />

Institute of Psychiatry, University of London. Across his subsequent career, he<br />

has sought to harness these two distinctive facets of his discipline to shed light<br />

on the cognitive basis of emotional vulnerability and pathology. His work has<br />

been guided by three complementary objectives: 1) to delineate the patterns of<br />

selective information processing that characterise emotional vulnerability and<br />

dysfunction; 2) to determine the causal nature of the association between each<br />

such processing bias and emotional disposition; and 3) to design and evaluate<br />

methods of attenuating emotional vulnerability by directly altering the cognitive<br />

biases that operate to functionally sustain it. He has played a major role in the<br />

development of influential new intervention approaches that contribute to the<br />

treatment of emotional dysfunction, and related clinical conditions, through the<br />

use of computer-based cognitive bias modification procedures.<br />

Colin joined the Australian tertiary sector in 1987, and commenced his position<br />

at The University of Western Australia in 1989. Since then, his research has<br />

been continuously funded by the Australian Research Council, and by a range<br />

of international granting agencies. He was elected a Fellow of the Academy of<br />

Social Sciences in Australia in 2002. Colin has held recent editorial positions<br />

with the Journal of Abnormal Psychology, Cognitive Therapy and Research, the<br />

Journal of Behaviour Therapy and Experimental Psychiatry, and Emotion, and<br />

has carried out a wide variety of responsibilities within the Australian University<br />

context. He has served as Head of Psychology, Associate Dean of Research, Chair<br />

of Academic Board, acting Pro Vice-Chancellor (Research & Innovation), national<br />

auditor for Australian University Quality Agency, and international auditor for<br />

overseas university quality agencies, including South Africa’s Council of Higher<br />

Education, and Saudi Arabia’s National Commission for Academic Accreditation<br />

and Assessment.<br />

Dr Chris Roberts has been the CEO of Cochlear Limited (ASX:COH) since February<br />

2004. He has over 36 years experience in international medical device businesses,<br />

including renal (dialysis), orthopaedics (electrical bone growth stimulation),<br />

cardiology (pacemakers), respiratory and sleep medicine (CPAP) and otology<br />

(cochlear implants).<br />

He served on the National Health and Medical Research Council, Australia<br />

(2003–2006). Chris is a director of ResMed Ltd and Research Australia,<br />

(Chairman of Research Australia from 2004-2010). He is a member of: The New<br />

South Wales Innovation and Productivity Council; the UNSW Faculty of Medicine<br />

Advisory Council; the Macquarie University Foundation Board of Patrons and; the<br />

University of Technology Sydney Vice-Chancellor’s Industrial Advisory Board.<br />

Chris holds a BE in Chemical Engineering (Honours) (UNSW), an MBA (Macquarie),<br />

a PhD (UNSW), and a HonDSc (Macquarie). He is a Fellow of the Academy of<br />

Technological Sciences and Engineering (FTSE), Fellow of the Australian Institute<br />

of Company Directors (FAICD), and Fellow of The Institution of Engineers Australia<br />

(FIEAust).<br />

7


SPEAKERS<br />

Dr Nicola Lake is a Melbourne-based Consultant within the Thomson Reuters<br />

IP Analytics Group delivering research and analysis projects to clients. She<br />

also provides expert insight and best practice knowledge on Thomson Reuters’<br />

products and services.<br />

Nicola formulated the methodology for the Thomson Reuters Innovation Awards<br />

<strong>2012</strong> together with Bob Stembridge, a London-based Customer Relations<br />

Manager. Bob was a pivotal member of the team responsible for the methodology<br />

behind the “Thomson Reuters Top 100 Innovators Program”. He has over 35 years<br />

of experience working with patent data and is (among other things) a member<br />

of the Patent Information User Group (PIUG) and the current Secretary of the<br />

Confederacy of European Patent Information User Group (CEPIUG).<br />

Prior to joining Thomson Reuters, Nicola worked for 8 years as an Australian<br />

Patent Attorney. For the last 5 years she worked together with Peter Huntsman in<br />

the Materials Science group at Davies Collison Cave (DCC). Before joining DCC,<br />

she undertook her traineeship at Madderns Patent and TM Attorneys based in<br />

Adelaide, South Australia.<br />

Nicola’s background in chemistry brought her to Australia in 2000 to undertake<br />

a Ph.D. in Applied Science at the Ian Wark Research Institute (“The Wark”). She<br />

also has a Masters in IP from the University of Technology Sydney, a Masters in the<br />

Management of IP from Queen Mary and Westfield College, University of London<br />

and a First Class Honours degree in Chemistry with Law from the University of<br />

Essex.<br />

Laurie Wilson has been a director of the National Press Club since 1992. He<br />

succeeded Ken Randall as President in 2010 having previously served as the<br />

NPC’s Treasurer.<br />

Laurie is a freelance journalist and consultant. He is a former political correspondent<br />

and Canberra Bureau Chief for the 7 Network, political correspondent for the 9<br />

Network and Secretary of the Federal Parliamentary Press Gallery.<br />

He began his career in the media as a proofreader on The Canberra Times while<br />

still at university and has worked both as a journalist and in media management.<br />

He was a senior reporter and news anchor for the 7 Network in Melbourne; was<br />

appointed General Manager (Corporate & Government Relations) and Group<br />

General Manager (Broadcasting) of the regional Victorian broadcast group Vic-<br />

TV; and has worked in a number of other management and board roles including<br />

a period as Executive Director of International Public Relations P/L and as a<br />

director of the Wesgo radio network.<br />

He studied journalism and economics at the University of Canberra and completed<br />

postgraduate studies in business administration at Melbourne’s Swinburne<br />

University of Technology.<br />

8


CITATION & INNOVATION AWARD<br />

WINNERS <strong>2012</strong><br />

Methodology - Citation Awards <strong>2012</strong><br />

This exploration of Australian research began with an identification of fields which were strengths for the<br />

country, by a combination of three criteria: first, how many papers Australian researchers published; second,<br />

how great a proportion of the field globally Australian research represented; and third, the level of impact,<br />

measured in <strong>citation</strong>s, relative to global performance in the field.<br />

The next step was to consider individuals who contribute to those fields. All Australian-affiliated authors<br />

from papers published between 2002 and October 2011, in journals indexed in Thomson Reuters’ Web of<br />

Science, were reviewed. A shortlist of researchers in each field was established by finding those authors who<br />

had published a given number of papers, each of which had been cited that given number of times – a metric<br />

called the h-index. This meant that only researchers who had made a strong contribution in terms of both<br />

quality and quantity were considered. Because field activity can vary widely, adjustments were made in the<br />

threshold levels for each field to eliminate false leads and focus on those researchers with substantial and<br />

long-term contributions.<br />

The shortlist was then ranked by average <strong>citation</strong>s per paper received, and the highest ranking author currently<br />

and actively producing research output was identified. This ensured that researchers would be selected who<br />

had a proven track record of high-impact research over the course of the ten year period. Where variation<br />

between the top and second ranked candidates was less than one <strong>citation</strong> per article, a second metric, average<br />

percentile, was used to differentiate them. This metric looks at how highly ranked a paper is by <strong>citation</strong>s<br />

against papers of the same type, published in the same year and in the same field, thereby allowing accurate<br />

comparison of the candidates’ impact.<br />

Field of Study Names Institution H-Index Cites Publications<br />

Astronomy &<br />

Astrophysics<br />

Biochemistry &<br />

Molecular Biology<br />

Biodiversity<br />

Conservation<br />

Professor<br />

Karl Glazebrook<br />

9<br />

Swinburne<br />

University of<br />

Technology<br />

Professor Terry Speed Walter and Eliza<br />

Hall Institute of<br />

Medical Research<br />

Dr Jane Elith University of<br />

Melbourne<br />

Ecology Professor<br />

Ove Hoegh-Guldberg<br />

University of<br />

Queensland<br />

69 22,245 181<br />

51 19,623 263<br />

25 2,986 42<br />

39 8,623 172<br />

Economics Dr Tommy Wiedmann CSIRO 15 574 25<br />

Environmental Studies Dr Shaobin Wang Curtin University 32 3,018 129<br />

Geosciences Professor<br />

Kurt Lambeck<br />

Immunology Professor<br />

Fabienne Mackay<br />

Australian<br />

National<br />

University<br />

Monash<br />

University<br />

Neurosciences Dr Greg Stuart Australian<br />

National<br />

University<br />

52 9,682 217<br />

46 8,297 105<br />

39 6,585 71<br />

Plant Sciences Professor Rana Munns CSIRO 45 9,848 114<br />

Psychology Professor<br />

Colin MacLeod<br />

Public, Environmental<br />

& Occupational Health<br />

University<br />

of Western<br />

Australia<br />

Dr Evie Leslie Flinders<br />

University<br />

25 5,062 53<br />

18 2,149 36


CITATION & INNOVATION AWARD<br />

WINNERS <strong>2012</strong><br />

Methodology - Innovation Awards <strong>2012</strong><br />

The methodology used to determine the <strong>2012</strong> Australian Innovation Award winners is based closely on the<br />

methodology used in the Thomson Reuters Top 100 Global Innovators Program. The methodology used<br />

to determine the Top 100 Global Innovators was developed by Thomson Reuters and discussed with and<br />

approved by several IP-savvy, external organisations.<br />

This is the first time Thomson Reuters has awarded <strong>innovation</strong> and entrepreneurship in Australia. Seven<br />

<strong>awards</strong> are presented: Large Corporate and SME Corporate (Biotechnology/Medical Devices), Large Corporate<br />

and SME Corporate (Technology), Government Funded R&D, University R&D and Best Academic/Corporate<br />

Collaboration. The <strong>awards</strong> recognise Australian <strong>innovation</strong> resulting from institutions and large and Smallto-Medium<br />

sized (SME) commercial enterprises headquartered in Australia. Australian SME Corporations are<br />

those with less than 200 employees.<br />

The research and analyses used to determine the award winners was performed using Thomson Reuters’<br />

Derwent World Patents Index® (DWPI), Thomson Innovation®, the Thomson Reuters IP intelligence and<br />

collaboration platform, and Thomson Data Analyzer®. Four indicators were used to determine the winners:<br />

• VOLUME: The top 10 most prolific patent filers in Australia over the last 5 years were identified. These<br />

organisations became the “candidate organisations”.<br />

• SUCCESS: For each candidate organisation, the number of granted patents to total number of new<br />

inventions filed in the last 5 years was used as a measure of “success”.<br />

• GLOBALISATION: The number of inventions filed in the last 5 years that have quadrilateral patents in their<br />

patent families, according to the Thomson Reuters Quadrilateral Patent Index was calculated for each<br />

candidate organisation.<br />

• INFLUENCE: The impact of an invention can be determined by looking at how often it is subsequently<br />

cited down the line. Citation counts were determined for each of the candidate organisations to provide a<br />

measure of the “influence” of their inventions filed in the last 5 years.<br />

These indicators were used in combination to identify the <strong>2012</strong> Australian Innovation Award winners.<br />

Category Organisation<br />

Corporate – Bio/Med (Large) ResMed<br />

Corporate – Bio/Med (SME) CathRx<br />

Corporate – Tech (Large) Rio Tinto<br />

Corporate – Tech (SME) Demain Technology<br />

Government Funded Grains Research & Development Corporation<br />

University University of New South Wales<br />

Collaboration University of Queensland & Eden Innovation<br />

10


CITATION AWARDEES<br />

Research Field: Astronomy & Astrophysics<br />

Professor Karl Glazebrook<br />

Swinburne University of Technology<br />

John Street, Hawthorn<br />

VIC 3122<br />

Professor Karl Glazebrook is a University Distinguished Professor at Swinburne<br />

University. Karl’s research involves the areas of galaxy evolution over cosmic time,<br />

cosmology and astronomical instrumentation; he is an observational astronomer<br />

who uses large telescopes on the ground such as Keck, Gemini and the Hubble<br />

Space Telescope.<br />

Originally from the UK, Karl completed his PhD at Edinburgh (1992) and postdoctoral<br />

work in Durham and Cambridge before becoming a Staff Astronomer at<br />

the Anglo-Australian Observatory in Sydney. Karl became a Professor at Johns<br />

Hopkins University in Baltimore in the year 2000 and moved to Swinburne in<br />

2006.<br />

Research Field: Biochemistry & Molecular Biology<br />

Professor Terry Speed<br />

The Walter and Eliza Hall Institute of Medical Research<br />

1G Royal Parade, Parkville<br />

VIC 3052<br />

Professor Terry Speed is head of the Bioinformatics Division of the Walter & Eliza<br />

Hall Institute of Medical Research (WEHI). Originally trained in mathematics and<br />

statistics, he has had a lifelong interest in genetics.<br />

After teaching mathematics and statistics in universities in Australia and the<br />

United Kingdom, and a spell in the CSIRO’s Division of Mathematics and Statistics,<br />

he went to the Department of Statistics at the University of California, Berkeley<br />

(UC Berkeley) in 1987. Since that time his research and teaching interests have<br />

concerned the application of statistics to genetics and molecular biology. Within<br />

that subfield, eventually to be named bioinformatics, his interests are broad,<br />

including biomolecular sequence analysis, the mapping of genes in experimental<br />

animals and humans, and functional genomics.<br />

He has been particularly involved in the low-level analysis of microarray data,<br />

and more recently, of next-generation DNA sequence analysis. From 1997 to<br />

2009 he split his time 50:50 between WEHI and UC Berkeley. In 2009 he took up<br />

an NHMRC Australia Fellowship at WEHI and became emeritus professor at UC<br />

Berkeley, but he still has students, postdocs and collaborators there.<br />

*Mrs Freda Speed will be accepting this award on behalf Professor Terry Speed.<br />

11


CITATION AWARDEES<br />

Research Field: Biodiversity Conservation<br />

Dr Jane Elith<br />

The University of Melbourne<br />

Environmental Science<br />

School of Botany, Melbourne<br />

VIC 3010<br />

Dr Jane Elith is appointed as a research fellow at the University of Melbourne,<br />

funded by an ARC Future Fellowship. Her research spans theoretical,<br />

methodological, and applied aspects of methods for modelling and predicting<br />

distributions of species and communities, reflecting her interest in biodiversity<br />

and conservation and attraction towards quantitative methods.<br />

Jane’s projects have spanned terrestrial, freshwater and marine ecosystems,<br />

with a substantial emphasis on finding appropriate methods and making them<br />

accessible to end-users. Most recently Jane has started working on problems<br />

associated with modelling non-equilibrial situations, exploring appropriate<br />

methods for predicting both the potential spread of invasive species and the likely<br />

responses of the biota to climate change.<br />

*Mr Michael Bode, ARC Postdoctoral Fellow at the University of Melbourne’s<br />

School of Botany will be accepting this award on behalf of Dr Jane Elith.<br />

Research Field: Ecology<br />

Professor Ove Hoegh-Guldberg<br />

The University of Queensland<br />

Global Change Institute<br />

St Lucia<br />

QLD 4072<br />

Professor Ove Hoegh-Guldberg (BSc Hons., Sydney; PhD. UCLA) is the inaugural<br />

Director of the Global Change Institute (GCI) (www.gci.uq.edu.au) and Professor of<br />

Marine Science, at The University of Queensland (UQ) (www.uq.edu.au), Brisbane,<br />

Australia. He is deeply-motivated by a desire to communicate science effectively,<br />

undertake game-changing research and to find high-impact solutions to address<br />

several of the most pressing and serious challenges facing humanity worldwide,<br />

such as climate change, food security, clean energy and population growth.<br />

As Director of the GCI Ove has a key role in engaging with the UQ community and<br />

external stakeholders to create opportunities and build strong external links and<br />

networks for the institute. He heads a large research laboratory (over 30 researchers<br />

& students) that focuses on how global warming and ocean acidification are<br />

affecting and will affect coral reefs.<br />

Ove has held academic positions at UCLA, Stanford University, The University<br />

of Sydney and The University of Queensland and is a member of the Australian<br />

Climate Group; the Royal Society (London) Marine Advisory Network; and the<br />

Board of Editing Reviewers at Science Magazine. In 1999 he was awarded the<br />

Eureka Prize for his scientific research. He is the Queensland Smart State Premier’s<br />

Fellow (2008-2013).<br />

12


CITATION AWARDEES<br />

Research Field: Economics<br />

Dr Thomas Wiedmann<br />

CSIRO<br />

Ecosystem Sciences<br />

Ross Street, Black Mountain<br />

ACT 2601<br />

Dr Thomas (Tommy) Wiedmann is a Senior Research Scientist at CSIRO<br />

Ecosystem Sciences, Canberra, where he is involved with CSIRO’s Integrated<br />

Carbon Pathways project. His research fields are environmental input-output<br />

analysis, industrial ecology and sustainable consumption and production. Tommy<br />

develops and applies methods and models for integrated sustainability and<br />

scenario analysis. In 2009, he was the guest editor of a special issue of the journal<br />

Economic Systems Research on ‘Carbon Footprint and Input-Output Analysis’.<br />

Tommy is also an Adjunct Associate Professor at the Centre for Integrated<br />

Sustainability Analysis (ISA) in the School of Physics at the University of Sydney<br />

and Director at the Centre for Sustainability Accounting (CenSA) in York, UK.<br />

He has coordinated a number of research projects funded by European, UK and<br />

Australian Governments. Tommy holds a PhD in environmental and analytical<br />

chemistry from the University Of Ulm, Germany.<br />

Research Field: Environmental Studies<br />

Dr Shaobin Wang<br />

Curtin University of Technology<br />

Department of Chemical Engineering<br />

GPO Box U1987, Perth<br />

WA 6001<br />

Dr Shaobin Wang graduated from the University of Queensland with a PhD<br />

degree in chemical engineering. Currently he is an associate professor at<br />

Department of Chemical Engineering, Curtin University. His research areas focus<br />

on Nanomaterials, applied catalysis and environmental engineering. He has<br />

published more than 180 refereed journal and conference papers and he is on the<br />

editorial board of several international journals in catalysis and environmental<br />

science.<br />

13


CITATION AWARDEES<br />

Research Field: Geosciences<br />

Professor Kurt Lambeck<br />

Australian National University Research School of Earth Sciences<br />

Canberra<br />

ACT 0200<br />

Professor Kurt Lambeck’s research deals with the motions and deformations of the Earth, on time scales from<br />

hours to millions of years, with the objective of understanding the forces that shape the planet, including<br />

the interactions of the oceans, atmosphere and cryosphere with the solid part of the earth. He is the leading<br />

proponent of developing and integrating geodetic methods with other geoscience disciplines of geophysics,<br />

geology and environmental science and over a career of more than three decades he has played a central role<br />

in most of the significant advances in this field.<br />

His studies have led to improved understanding of the orbital movements of earth satellites, of the dynamics<br />

of the Earth system, and to predictive models of the planet’s behaviour. These contributions have crossed<br />

diverse sub-disciplines of geoscience but they all have the common goal of understanding the dynamics of the<br />

Earth system over a broad range of time and length scales.<br />

Kurt Lambeck is the immediate past president of the Australian Academy of Science and professor emeritus at<br />

the Australian National University. Currently he holds a Blaise Pascal Chair at the Ecole Normale Superieure,<br />

Paris. He is, amongst others, a member of the Royal Society, the French Academy of Science, and the US<br />

National Academy of Science.<br />

*Mr Andrew P. Roberts, Director Research School of Earth Sciences at the Australian National University<br />

will be accepting this award on behalf of Professor Kurt Lambeck.<br />

Research Field: Immunology<br />

Professor Fabienne Mackay<br />

Monash University<br />

Department of Immunology<br />

Alfred Medical Research & Education Precinct (AMREP)<br />

Level 2, Monash University Building<br />

Commercial Road, Melbourne<br />

VIC 3004<br />

Professor Fabienne Mackay obtained her Ph D in 1994 at the Louis Pasteur University in Strasbourg under the<br />

co-supervision of Dr Werner Lesslauer (Hoffmann La Roche, Basel Switzerland) and Prof. Diane Mathis (now<br />

at the Joslin Institute Boston USA). In 1994, Fabienne joined Biogen Idec Inc. in Boston where she dissected<br />

the role of a TNF-like ligand lymphotoxin-alpha/beta in autoimmunity and cancer. This work led to many<br />

patents and the development of two new treatments currently tested in the clinic.<br />

In 2000, Fabienne joined the Garvan Institute in Sydney as a Welcome Trust senior research fellow and was<br />

awarded a NHMRC program grant. Fabienne’s lab at the Garvan discovered the role of a new molecule named<br />

BAFF as a key B cell survival factor essential for the maturation of B-lymphocytes but also playing a role in<br />

autoimmunity, and became the leading group on BAFF research. In March 2006, Fabienne was appointed<br />

to Director of the Autoimmunity Research Unit and adjunct full professor at the Faculty of medicine of the<br />

University of New South Wales. Fabienne is a consultant for several biotech and pharmaceutical groups. In<br />

2007, she joined the national director board of the Australian Society of Medical Research (ASMR). In 2008,<br />

she was the NSW representative for the NHMRC Association for Research Fellows (NARF). Fabienne is an<br />

associate editor for several scientific journals including the Journal of Interferon & Cytokine Research and the<br />

European Journal of Immunology.<br />

In March 2009, Fabienne became the 5th Chair of the Department of Immunology, Monash University, AMREP<br />

campus. In July 2009, belimumab, a therapeutic antibody neutralising BAFF has met the primary endpoints<br />

in a phase III clinical trial with lupus patients and run by GSK and Human Genome Sciences. This clinical<br />

outcome validated a decade of Fabienne’s work on BAFF and autoimmunity.<br />

14


CITATION AWARDEES<br />

Research Field: Neuroscience<br />

Professor Greg Stuart<br />

The Australian National University<br />

ANU College of Medicine, Biology and Environment<br />

Canberra<br />

ACT 0200<br />

Professor Greg Stuart is currently Head of the Eccles Institute of Neuroscience at<br />

the John Curtin School of Medical Research at the Australian National University.<br />

He did his undergraduate at Monash University, majoring in Physiology, before<br />

going on to do a PhD in Neuroscience at the ANU. He has developed and pioneered<br />

methods that have allowed neuroscientists to probe the function of nerve cells at<br />

an unprecedented level, and is considered a world expert on the physiology of<br />

neuronal dendrites.<br />

He has received a number of national and international fellowships and <strong>awards</strong>,<br />

and was recently appointed to the Australian Academy of Science in recognition<br />

of his seminal contributions to understanding how information is processed by<br />

individual nerve cells within the brain.<br />

*Professor Andrew Cockburn, Director ANU College of Medicine, Biology and<br />

Environment will be accepting this award on behalf of Professor Greg Stuart.<br />

Research Field: Plant Sciences<br />

Professor Rana Munns<br />

CSIRO<br />

Plant Industry<br />

Black Mountain Laboratories Clunies<br />

Ross Street, Black Mountain<br />

ACT 2601<br />

Professor Rana Munns has worked towards improving crop production on soils<br />

that are dry or saline. She is now Honorary Fellow at CSIRO Plant Industry in<br />

Canberra, as well as Winthrop Professor at the University of Western Australia.<br />

She is a Fellow of the Australian Academy of Science. She is recognised<br />

internationally for her insights into the fundamental principles of salt tolerance,<br />

and for the applications of these insights.<br />

She characterised the critical processes for tolerance of salinity stress, and<br />

showed how these differ from tolerance of drought stress. This work produced a<br />

highly sensitive technique for identifying salt tolerant plants, and the discovery<br />

of important genes for salt tolerance. She led a research team that discovered<br />

novel genes for controlling sodium transport in ancestral wheat, crossed them<br />

into modern durum wheat, and showed that these increased yield in saline soil in<br />

farmers’ fields by 25%. This work has just been published in Nature Biotechnology.<br />

* Mr John Passioura, Honorary Research Fellow CSIRO Plant Industry will be<br />

accepting the award on behalf of Professor Rana Munns.<br />

15


CITATION AWARDEES<br />

Research Field: Psychology<br />

Professor Colin MacLeod<br />

The University of Western Australia<br />

School of Psychology<br />

35 Stirling Highway, Crawley<br />

WA 6009<br />

Professor Colin MacLeod is Winthrop Professor of Psychology, Australian Research Council Professorial Fellow,<br />

and Director of the Elizabeth Rutherford Memorial Centre for the Advancement of Research on Emotion<br />

(CARE), at the University of Western Australia (UWA). Colin completed training both as a cognitive psychologist,<br />

carrying out his research doctorate in this field at Oxford University, and as a clinician, undertaking clinical<br />

psychology training at the Institute of Psychiatry, University of London. Across his subsequent career, he has<br />

sought to harness these two distinctive facets of his discipline to shed light on the cognitive basis of emotional<br />

vulnerability and pathology. His work has been guided by three complementary objectives: 1) to delineate the<br />

patterns of selective information processing that characterise emotional vulnerability and dysfunction; 2) to<br />

determine the causal nature of the association between each such processing bias and emotional disposition;<br />

and 3) to design and evaluate methods of attenuating emotional vulnerability by directly altering the cognitive<br />

biases that operate to functionally sustain it. He has played a major role in the development of influential<br />

new intervention approaches that contribute to the treatment of emotional dysfunction, and related clinical<br />

conditions, through the use of computer-based cognitive bias modification procedures.<br />

Colin joined the Australian tertiary sector in 1987, and commenced his position at The University of Western<br />

Australia in 1989. Since then, his research has been continuously funded by the Australian Research Council,<br />

and by a range of international granting agencies. He was elected a Fellow of the Academy of Social Sciences in<br />

Australia in 2002. Colin has held recent editorial positions with the Journal of Abnormal Psychology, Cognitive<br />

Therapy and Research, the Journal of Behaviour Therapy and Experimental Psychiatry, and Emotion, and has<br />

carried out a wide variety of responsibilities within the Australian University context. He has served as Head<br />

of Psychology, Associate Dean of Research, Chair of Academic Board, acting Pro Vice-Chancellor (Research &<br />

Innovation), national auditor for Australian University Quality Agency, and international auditor for overseas<br />

university quality agencies, including South Africa’s Council of Higher Education, and Saudi Arabia’s National<br />

Commission for Academic Accreditation and Assessment.<br />

Research Field: Public, Environmental & Occupational Health<br />

Dr Evie Leslie<br />

Flinders University<br />

School of Medicine<br />

GPO Box 2100, Adelaide<br />

SA 5001<br />

Dr Evie Leslie is a senior researcher and behavioural scientist who took up her current role in the School<br />

of Medicine at Flinders University in early <strong>2012</strong>. Previously she was a Principal Research Fellow at Deakin<br />

University, and has held appointments at the University of Wollongong and the University of Queensland.<br />

Her research has a population health focus, with particular interests in healthy lifestyles (physical activity and<br />

nutrition behaviours), community health promotion and the role of community design and green spaces in<br />

maintaining health and well-being. Currently Evie is the coordinator for the evaluation of a large communitybased<br />

obesity prevention program called OPAL (Obesity Prevention and Lifestyle) which will be operating in<br />

20 communities in South Australia by the end of <strong>2012</strong>.<br />

Evie has completed an advanced training course on physical activity and public health at the US Centres<br />

for Disease Control and conducted her own program of research through an NHMRC Public Health Training<br />

Fellowship, examining the impacts of social and physical environments on physical activity behaviours.<br />

Her work includes innovative approaches linking behavioural and spatial epidemiology methods and she<br />

has published extensively on the ‘walkability’ of communities. Over her career she has worked with various<br />

government departments on research-related projects and has contributed to several evidence-based policy<br />

documents. She collaborates with researchers from a variety of disciplines including epidemiology, public<br />

health, urban planning, social geography, health psychology, exercise science, nutrition, medicine and<br />

behavioural epidemiology.<br />

16


INNOVATION AWARDEES<br />

Innovation Category: Corporate – Bio/Med (Large)<br />

ResMed Ltd<br />

1 Elizabeth Macarthur Drive<br />

Bella Vista<br />

NSW 2153<br />

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and<br />

distributor of medical equipment for treating, diagnosing, and managing sleepdisordered<br />

breathing and other respiratory disorders. The company is dedicated<br />

to developing innovative products to improve the lives of those who suffer from<br />

these conditions and to increasing awareness among patients and healthcare<br />

professionals of the potentially serious health consequences of untreated sleepdisordered<br />

breathing.<br />

When ResMed was formed in 1989, its primary purpose was to commercialise<br />

a device for treating obstructive sleep apnea (OSA), a major subset of SDB.<br />

Developed in 1981 by Professor Colin Sullivan and colleagues at the University<br />

of Sydney, nasal continuous positive airway pressure (CPAP) provided the first<br />

successful non-invasive treatment of OSA. Since 1989, ResMed has maintained<br />

its focus on SDB, which is gaining greater public and physician awareness.<br />

Operations have grown dramatically through the introduction of a number of<br />

highly innovative product lines.<br />

*Mr Mark Abourizk, Vice President of Intellectual Property & Legal Counsel at<br />

ResMed Limited will be accepting the award on behalf of ResMed Limited.<br />

Innovation Category: Corporate – Bio/Med (SME)<br />

CathRx<br />

5 Parkview Drive<br />

Homebush Bay<br />

NSW 2127<br />

CathRx is focussed on developing, patenting and producing a full range of high<br />

quality Electrophysiology (EP) Catheters, used in the diagnosis and treatment of<br />

cardiac arrhythmias. CathRx’s goal is to provide high quality EP Catheters at costs<br />

that will make EP procedures far more affordable. CathRx design a full range of<br />

EP Catheters, featuring durable materials to ensure high performance during<br />

use. CathRx also produce catheters that have a unique, patented design feature:<br />

Modular Construction. This enables manufacturing and remanufacturing with<br />

selected partners globally to drive huge hospital savings.<br />

CathRx is the only Catheter technology company in the world that offers<br />

Remanufacturable Catheters. This offers hospitals EP Catheters that have passed<br />

the same quality control tests that all new Catheters must pass, but at significantly<br />

reduced prices. CathRx has also designed and patented an Advanced AF Ablation<br />

program, which uses irrigated, multi-electrode, linear lesion technology. This<br />

technology has the potential to help patients worldwide with a safe and effective<br />

AF Ablation system.<br />

*Mr Roman Greifeneder, Director of Research & Development and Operations<br />

at CathRx Ltd will be accepting the award on behalf of CathRx Ltd.<br />

17


INNOVATION AWARDEES<br />

Innovation Category: Corporate – Tech (Large)<br />

Rio Tinto Ltd<br />

Head Office<br />

120 Collins Street<br />

Melbourne<br />

VIC 3000<br />

Rio Tinto is a leading international mining group, combining Rio Tinto plc, a London<br />

listed public company headquartered in the UK, and Rio Tinto Limited, which is listed<br />

on the Australian Stock Exchange, with executive offices in Melbourne. The two<br />

companies are joined in a dual listed companies (DLC) structure as a single economic<br />

entity, called the Rio Tinto Group.<br />

To deliver superior returns to shareholders over time, Rio Tinto takes a long term<br />

and responsible approach to the Group’s business. This means concentrating on<br />

the development of first class orebodies into large, long life and efficient operations,<br />

capable of sustaining competitive advantage through business cycles. Rio Tinto is<br />

a world leader in finding, mining and processing the Earth’s mineral resources. Our<br />

products help fulfil vital consumer needs and improve living standards. Rio Tinto<br />

operate, and eventually close, our operations safely, responsibly and sustainably.<br />

Rio Tinto’s interests are diverse both in geography and product. Rio Tinto work in<br />

some of the world’s most difficult terrains and climates. Most of their assets are in<br />

Australia and North America, but they also operate in Europe, South America, Asia<br />

and Africa. Their businesses include open pit and underground mines, mills, refineries<br />

and smelters as well as a number of research and service facilities.<br />

Rio Tinto operates as a global organisation, sharing best practices across the Group.<br />

Their values - accountability, respect, teamwork and integrity - are expressed through<br />

their business principles, policies and standards. Rio Tinto set these out in our<br />

worldwide code of business conduct, the way they work. Their values underpin the<br />

way they manage the economic, social and environmental effects of their operations,<br />

and how they govern their business.<br />

* Mr John McGagh, Head of Innovation at Rio Tinto will be accepting the award on<br />

behalf of Rio Tinto.<br />

18


INNOVATION AWARDEES<br />

Innovation Category: Corporate – Tech (SME)<br />

Demain International Pty Ltd<br />

Level 1, 13 Corporate Drive<br />

Heatherton<br />

VIC 3202<br />

Demain is the world’s largest independent developer specialising in power tools and uses its unique ICADS<br />

(Innovation Creation and Development System) to deliver genuine improvement to the user in the areas of<br />

safety, endurance, comfort, control, ergonomics and speed of a power tool.<br />

Demain International P/L was founded in 2001 with the aim of designing and developing true power tool<br />

<strong>innovation</strong> for the global market. Since 2001, Demain has developed a portfolio of <strong>innovation</strong> that includes<br />

market leading technologies such as Power-Tite, Air Thru and Flashcell. Demain International’s highly<br />

awarded <strong>innovation</strong>s and technologies have been implemented in power tools in most of the major markets<br />

of the world.<br />

* Mr Ben Van der Linde, General Manager – Technology will be accepting the award on behalf of Demain<br />

International Ltd.<br />

Innovation Category: Government Funded<br />

The Grains Research & Development Corporation<br />

PO Box 5367<br />

Kingston<br />

ACT 2604<br />

The Grains Research & Development Corporation is one of the world’s leading grains research organisations,<br />

responsible for planning, investing and overseeing research and development (R&D), delivering improvements<br />

in production, sustainability and profitability across the Australian grains industry. GRDC is a statutory<br />

corporation, founded in 1990 under the Primary Industries and Energy Research and Development Act 1989<br />

(PIERD Act), it is subject to accountability and reporting obligations set out in the Commonwealth Authorities<br />

and Companies Act 1997 (CAC Act). The GRDC’s portfolio department is the Australian Government<br />

Department of Agriculture, Fisheries and Forestry (DAFF).<br />

The GRDC’s mission is to invest in R&D for the greatest benefit to its stakeholders - grain growers and the<br />

Australian Government. This involves coordinating and funding the activities; monitoring, evaluating and<br />

reporting on their impact; and facilitating the dissemination, adoption and commercialisation of their results.<br />

The GRDC also contributes to the development of strategic national approaches to grains industry R&D, to<br />

reduce fragmentation and duplication, and to help address industry-wide issues such as biosecurity and<br />

climate change. The Corporation links innovative research with industry needs. The GRDC’s vision is for a<br />

profitable, internationally competitive and ecologically sustainable grains industry.<br />

Collaboration is at the heart of the GRDC’s approach to adding value to the Australian grains industry. The<br />

majority of the GRDC’s investment in R&D is with partners that co-fund the work as well as conducting the<br />

activities. This includes partnerships to provide a path to market for the results of R&D projects.<br />

The GRDC’s research portfolio covers 25 leviable crops spanning temperate and tropical cereals, oilseeds and<br />

pulses, worth over $7 billion a year in farm production, alone. Funding is provided through a levy on grain<br />

growers. This is determined each year by the grains industry’s peak body. The Australian Government matches<br />

this funding, up to an agreed ceiling.<br />

* Mr Paul Meibusch, Manager Commercial Farm Technologies will be accepting the award on behalf of<br />

GRDC.<br />

19


INNOVATION AWARDEES<br />

Innovation Category: University<br />

The University of New South Wales<br />

Sydney<br />

NSW 2052<br />

The University of New South Wales is one of Australia’s leading research and<br />

teaching universities. At UNSW, they take pride in the broad range and high<br />

quality of our teaching programs. UNSW’s teaching gains strength and currency<br />

from their research activities and international nature; they have a strong regional<br />

and global engagement.<br />

In developing new ideas and promoting lasting knowledge UNSW are creating an<br />

academic environment where outstanding students and scholars from around the<br />

world can be inspired to excel in their programs of study and research. Partnerships<br />

with both local and global communities allow UNSW to share knowledge, debate<br />

and research outcomes. UNSW’s public events include concert performances,<br />

open days and public forums on issues such as the environment, healthcare and<br />

global politics.<br />

*Dr Jim Henderson, General Manager of Life Sciences NewSouth Innovations will<br />

be accepting the award on behalf of the University of New South Wales.<br />

Innovation Category: Collaboration<br />

The University of Queensland<br />

Brisbane<br />

QLD 4072<br />

The University of Queensland (UQ) is one of Australia’s premier learning and<br />

research institutions. It is the oldest university in Queensland and has produced<br />

almost 197,000 graduates since opening in 1911. Its graduates have become<br />

leaders in all areas of society and industry.<br />

UQ is one of the three Australian members of the global Universitas 21 alliance.<br />

This group aims to enhance the quality of university outcomes through<br />

international benchmarking and a joint venture e-learning project with The<br />

Thomson Corporation.<br />

UQ is a founding member of the national Group of Eight (Go8) a coalition of<br />

leading Australian universities, intensive in research and comprehensive in<br />

general and professional education. Collectively, Group of Eight members account<br />

for 70 percent of all research income in Australia’s university system, enrol more<br />

than half of all higher degree by research students, hold over 90 percent of US<br />

patents for inventions and generate 80 percent of spin-off companies created by<br />

Australian universities.<br />

UQ is a pacesetter in discovery and translational research across a broad spectrum<br />

of exciting disciplines, ranging from bioscience and nanotechnology to mining,<br />

engineering, social science and humanities.<br />

Its eight internationally significant research institutes are drawcards for an<br />

ever-expanding community of scientists, researchers and commercialisation<br />

experts. UQ is noted for supporting early- and mid-career researchers, as seen<br />

in their commitment to research training; in 2010, UQ celebrated its 9000th PhD<br />

graduation. UQ currently has 4039 Research Higher Degree students, including<br />

3593 PhD students. In 2010, 534 Research Higher Degrees were awarded.<br />

20


INNOVATION AWARDEES<br />

Innovation Category: Collaboration<br />

Eden Innovation<br />

Subsidiary of Eden Energy Ltd<br />

Level 40, Exchange Plaza 2<br />

The Esplanade<br />

Perth<br />

WA 6000<br />

Eden Energy Ltd is a diversified clean energy company that listed on the Australian<br />

Stock Exchange in May 2006. Eden has interests in hydrogen production, storage<br />

and transport fuel systems, including the low emission Hythane hydrogenmethane<br />

blend, coal seam and abandoned mine methane in the UK, conventional<br />

gas in SA, low temperature pyrolysis research into hydrogen production and<br />

geothermal energy production.<br />

All these aspects of Eden’s business are part of an integrated strategy to become<br />

a major global participant in the alternate energy market, particularly focussing<br />

on the clean energy transport market, producing hydrogen without any carbon<br />

emissions, transporting the hydrogen to markets and providing the engines to<br />

power hydrogen-based transport and energy solutions.<br />

*Professor Alan Lawson, Deputy Vice-Chancellor (Research) will be accepting<br />

the award on behalf of the University of Queensland and Eden Innovation.<br />

21


ABOUT THOMSON REUTERS<br />

Thomson Reuters is the world’s leading source of intelligent information for businesses and professionals. We combine<br />

industry expertise with innovative technology to deliver critical information to leading decision makers in the financial<br />

and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world’s most<br />

trusted news organisation. With headquarters in New York and major operations in London and Eagan, Minnesota,<br />

Thomson Reuters employs approximately 60,000 people and operates in over 100 countries.<br />

For over half a century, Thomson Reuters has pioneered the world of <strong>citation</strong> indexing and analysis, connecting scientific<br />

and scholarly discoveries around the world. Our founder Dr Eugene Garfield is one of the pioneers in the field of<br />

bibliometrics. He developed the concept of <strong>citation</strong> linking to track developments in science and created the concepts<br />

behind our flagship service, the Web of Science. Thomson Reuters is an undisputed leader in providing publication and<br />

<strong>citation</strong> data for both knowledge discovery and evaluation of research.<br />

Our publication and <strong>citation</strong> data goes back in time to 1900 and is sourced from peer-reviewed international scholarly<br />

journals, conference proceeding and selected books. Coverage from both Web of Science and our other specialised<br />

databases allows focused research in all disciplines across the sciences, social sciences and arts & humanities.<br />

The IP Solutions business of Thomson Reuters is the leading provider of intellectual property content, solutions and<br />

services. Thomson Reuters helps professionals worldwide drive <strong>innovation</strong>, protect intellectual assets and maximize the<br />

value of their IP by providing solutions that power the intellectual property lifecycle.<br />

For more information, go to ip-science.<strong>thomson</strong><strong>reuters</strong>.com.au<br />

22


FOR GENERAL ENQUIRES ABOUT:<br />

Thomson Reuters Australia,<br />

please contact:<br />

+61 2 8587 7636<br />

ts.info.anz@<strong>thomson</strong><strong>reuters</strong>.com<br />

FOR MORE INFORMATION ABOUT:<br />

Thomson Reuters patent and trademark services and analysis,<br />

please contact:<br />

Andrew O’Brien<br />

+61 3 8684 2036<br />

+61 4 0291 8215<br />

andrew.obrien@<strong>thomson</strong><strong>reuters</strong>.com<br />

Thomson Reuters science & scholarly research services and analysis,<br />

please contact:<br />

Geeho Liu<br />

+61 2 8587 7545<br />

+61 4 1681 4680<br />

geeho.liu@<strong>thomson</strong><strong>reuters</strong>.com<br />

© Thomson Reuters <strong>2012</strong>. All rights reserved. 49001013<br />

Republication or redistribution of Thomson Reuters content, including by framing or similar means, is prohibited<br />

without the prior written consent of Thomson Reuters. ‘Thomson Reuters’ and the Thomson Reuters logo are registered<br />

trademarks and trademarks of Thomson Reuters and its affiliated companies.<br />

<strong>thomson</strong><strong>reuters</strong>.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!